[Effects of aprindine on the induction and termination of supraventricular tachycardia in patients with accessory pathway syndrome].
D000328:Adult; D001073:Aprindine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007192:Indenes / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D013610:Tachycardia / Q000188:drug therapy*; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications*
D007192:Indenes; D001073:Aprindine